Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Briefing
  • Published:

Framework for predicting alloreactivity in hematopoietic cell transplants

The therapeutic principle of allogeneic hematopoietic cell transplantation, one the most common forms of cancer immunotherapy, is alloreactivity, yet its molecular determinants remain largely unknown. An analytical framework now enables personalized assessment of alloreactivity from whole-exome sequencing of donor–recipient pairs, to help with prognostication of disease relapse and immune-mediated complications.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: A framework for systematic mHAg discovery.

References

  1. Blazar, B. R., Hill, G. R. & Murphy, W. J. Dissecting the biology of allogeneic HSCT to enhance the GvT effect whilst minimizing GvHD. Nat. Rev. Clin. Oncol. 17, 475–492 (2020). A review of our current understanding of the GvL effect.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Shlomchik, W. D. Graft-versus-host disease. Nat. Rev. Immunol. 7, 340–352 (2007). A review that provides mechanistic insights into GvHD immunobiology.

    Article  CAS  PubMed  Google Scholar 

  3. Biernacki, M. A., Sheth, V. S. & Bleakley, M. T cell optimization for graft-versus-leukemia responses. JCI Insight 5, e134939 (2020). A review that describes the alloantigenic and antigenic landscapes after transplant as well as strategies to augment the GvL effect.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Griffioen, M., van Bergen, C. A. & Falkenburg, J. H. Autosomal minor histocompatibility antigens: how genetic variants create diversity in immune targets. Front. Immunol. 7, 100 (2016). A review that provides a comprehensive compendium of known mHAgs.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Mutis, T., Xagara, A. & Spaapen, R. M. The connection between minor H antigens and neoantigens and the missing link in their prediction. Front. Immunol. 11, 1162 (2020). A review that establishes a fascinating parallelism between neoantigens and mHAgs.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Cieri, N. et al. Systematic identification of minor histocompatibility antigens predicts outcomes of allogeneic hematopoietic cell transplantation. Nat. Biotechnol. https://doi.org/10.1038/s41587-024-02348-3 (2024).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Framework for predicting alloreactivity in hematopoietic cell transplants. Nat Biotechnol (2024). https://doi.org/10.1038/s41587-024-02354-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s41587-024-02354-5

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing